Key Findings

The study identifies a novel plasmid-mediated cephalosporinase, CMY-9, which confers resistance to several β-lactam antibiotics, including ceftazidime, cefpirome, cefotaxime, cefminox, cefoxitin, and moxalactam. The gene was cloned and characterized in E. coli.